Cargando…
The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes?
Besides bacteria, fungi, protists and archaea, the vaginal ecosystem also contains a range of prokaryote- and eukaryote-infecting viruses, which are collectively referred to as the “virome”. Despite its well-described role in the gut and other environmental niches, the vaginal virome remains underst...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472209/ https://www.ncbi.nlm.nih.gov/pubmed/32751611 http://dx.doi.org/10.3390/v12080832 |
_version_ | 1783578935763664896 |
---|---|
author | Happel, Anna-Ursula Varsani, Arvind Balle, Christina Passmore, Jo-Ann Jaspan, Heather |
author_facet | Happel, Anna-Ursula Varsani, Arvind Balle, Christina Passmore, Jo-Ann Jaspan, Heather |
author_sort | Happel, Anna-Ursula |
collection | PubMed |
description | Besides bacteria, fungi, protists and archaea, the vaginal ecosystem also contains a range of prokaryote- and eukaryote-infecting viruses, which are collectively referred to as the “virome”. Despite its well-described role in the gut and other environmental niches, the vaginal virome remains understudied. With a focus on sexual and reproductive health, we summarize the currently known components of the vaginal virome, its relationship with other constituents of the vaginal microbiota and its association with adverse health outcomes. While a range of eukaryote-infecting viruses has been described to be present in the female genital tract (FGT), few prokaryote-infecting viruses have been described. Literature suggests that various vaginal viruses interact with vaginal bacterial microbiota and host immunity and that any imbalance thereof may contribute to the risk of adverse reproductive health outcomes, including infertility and adverse birth outcomes. Current limitations of vaginal virome research include experimental and analytical constraints. Considering the vaginal virome may represent the missing link in our understanding of the relationship between FGT bacteria, mucosal immunity, and adverse sexual and reproductive health outcomes, future studies evaluating the vaginal microbiome and its population dynamics holistically will be important for understanding the role of the vaginal virome in balancing health and disease. |
format | Online Article Text |
id | pubmed-7472209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74722092020-09-04 The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? Happel, Anna-Ursula Varsani, Arvind Balle, Christina Passmore, Jo-Ann Jaspan, Heather Viruses Review Besides bacteria, fungi, protists and archaea, the vaginal ecosystem also contains a range of prokaryote- and eukaryote-infecting viruses, which are collectively referred to as the “virome”. Despite its well-described role in the gut and other environmental niches, the vaginal virome remains understudied. With a focus on sexual and reproductive health, we summarize the currently known components of the vaginal virome, its relationship with other constituents of the vaginal microbiota and its association with adverse health outcomes. While a range of eukaryote-infecting viruses has been described to be present in the female genital tract (FGT), few prokaryote-infecting viruses have been described. Literature suggests that various vaginal viruses interact with vaginal bacterial microbiota and host immunity and that any imbalance thereof may contribute to the risk of adverse reproductive health outcomes, including infertility and adverse birth outcomes. Current limitations of vaginal virome research include experimental and analytical constraints. Considering the vaginal virome may represent the missing link in our understanding of the relationship between FGT bacteria, mucosal immunity, and adverse sexual and reproductive health outcomes, future studies evaluating the vaginal microbiome and its population dynamics holistically will be important for understanding the role of the vaginal virome in balancing health and disease. MDPI 2020-07-30 /pmc/articles/PMC7472209/ /pubmed/32751611 http://dx.doi.org/10.3390/v12080832 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Happel, Anna-Ursula Varsani, Arvind Balle, Christina Passmore, Jo-Ann Jaspan, Heather The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
title | The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
title_full | The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
title_fullStr | The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
title_full_unstemmed | The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
title_short | The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
title_sort | vaginal virome—balancing female genital tract bacteriome, mucosal immunity, and sexual and reproductive health outcomes? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472209/ https://www.ncbi.nlm.nih.gov/pubmed/32751611 http://dx.doi.org/10.3390/v12080832 |
work_keys_str_mv | AT happelannaursula thevaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT varsaniarvind thevaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT ballechristina thevaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT passmorejoann thevaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT jaspanheather thevaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT happelannaursula vaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT varsaniarvind vaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT ballechristina vaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT passmorejoann vaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes AT jaspanheather vaginalviromebalancingfemalegenitaltractbacteriomemucosalimmunityandsexualandreproductivehealthoutcomes |